233 related articles for article (PubMed ID: 12520751)
21. A phase III of cisplatinum versus cisplatinum-etoposide for previously untreated squamous cell carcinoma of the head and neck.
Marechal F; Nasca S; Morel M; Jezekova D; Coninx P; Legros M; Nguyen TD; Cattan A
Anticancer Res; 1987; 7(3 Pt B):455-8. PubMed ID: 3307601
[TBL] [Abstract][Full Text] [Related]
22. Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.
Eckardt JR; von Pawel J; Papai Z; Tomova A; Tzekova V; Crofts TE; Brannon S; Wissel P; Ross G
J Clin Oncol; 2006 May; 24(13):2044-51. PubMed ID: 16648504
[TBL] [Abstract][Full Text] [Related]
23. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin for small-cell lung cancer.
Aisner J; Abrams J
Semin Oncol; 1989 Aug; 16(4 Suppl 6):2-9. PubMed ID: 2548282
[TBL] [Abstract][Full Text] [Related]
27. Topotecan and etoposide as first-line therapy for extensive disease small cell lung cancer: a phase II trial of a platinum-free regimen.
Reck M; Groth G; Buchholz E; Goetz E; Gatzemeier U; Manegold C
Lung Cancer; 2005 Jun; 48(3):409-13. PubMed ID: 15893010
[TBL] [Abstract][Full Text] [Related]
28. Management of small cell lung cancer in elderly.
Satoh H; Ishikawa H; Funayama Y; Yamashita YT; Kamma H; Ohtsuka M; Sekizawa K
Anticancer Res; 1999; 19(5C):4507-10. PubMed ID: 10650801
[TBL] [Abstract][Full Text] [Related]
29. Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer.
Lorigan P; Woll PJ; O'Brien ME; Ashcroft LF; Sampson MR; Thatcher N
J Natl Cancer Inst; 2005 May; 97(9):666-74. PubMed ID: 15870437
[TBL] [Abstract][Full Text] [Related]
30. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer.
Schild SE; Bonner JA; Shanahan TG; Brooks BJ; Marks RS; Geyer SM; Hillman SL; Farr GH; Tazelaar HD; Krook JE; Geoffroy FJ; Salim M; Arusell RM; Mailliard JA; Schaefer PL; Jett JR
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):943-51. PubMed ID: 15234027
[TBL] [Abstract][Full Text] [Related]
31. Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly.
Schild SE; Stella PJ; Brooks BJ; Mandrekar S; Bonner JA; McGinnis WL; Mailliard JA; Krook JE; Deming RL; Adjei AA; Jatoi A; Jett JR
Cancer; 2005 Jun; 103(11):2349-54. PubMed ID: 15852407
[TBL] [Abstract][Full Text] [Related]
32. Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) study.
Ardizzoni A; Favaretto A; Boni L; Baldini E; Castiglioni F; Antonelli P; Pari F; Tibaldi C; Altieri AM; Barbera S; Cacciani G; Raimondi M; Tixi L; Stefani M; Monfardini S; Antilli A; Rosso R; Paccagnella A
J Clin Oncol; 2005 Jan; 23(3):569-75. PubMed ID: 15659503
[TBL] [Abstract][Full Text] [Related]
33. [Single high-dose and fractionated low dose cisplatin in the EP protocol for advanced NSCLC--a prospective randomized trial on 72 patients].
Ying Z; Guan C; Huang N
Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):226-8. PubMed ID: 7656833
[TBL] [Abstract][Full Text] [Related]
34. Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial.
Oh IJ; Kim KS; Park CK; Kim YC; Lee KH; Jeong JH; Kim SY; Lee JE; Shin KC; Jang TW; Lee HK; Lee KY; Lee SY
BMC Cancer; 2016 Aug; 16(1):690. PubMed ID: 27566413
[TBL] [Abstract][Full Text] [Related]
35. Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: a Phase III study.
Dimitroulis J; Rapti A; Stathopoulos GP; Rigatos S; Stathopoulos J; Koutantos J; Athanasiadis A; Tsikritsaki K; Karaindros D; Katis K; Antoniou D; Toumbis M; Giamboudakis P
Oncol Rep; 2008 Oct; 20(4):879-84. PubMed ID: 18813830
[TBL] [Abstract][Full Text] [Related]
36. Comparison of carboplatin/etoposide/vincristine with cisplatin/etoposide as combination chemotherapy for small cell lung cancer.
Kumagai M; Kutsuzawa T; Fuyuno G; Kondo T; Shioya S; Ohta Y
Tokai J Exp Clin Med; 1995 Dec; 20(4-6):209-14. PubMed ID: 8956462
[TBL] [Abstract][Full Text] [Related]
37. A phase I trial defining the maximum tolerated systemic exposure of topotecan in combination with Carboplatin and Etoposide in extensive stage small cell lung cancer.
Gillenwater HH; McCune JS; Lindley C; Faucette S; Shord S; Donahue A; Socinski MA; Stewart CF; Zamboni WC; Kirstein MN; Moore D
Cancer Invest; 2005; 23(6):511-9. PubMed ID: 16203659
[TBL] [Abstract][Full Text] [Related]
38. Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.
Bork E; Ersbøll J; Dombernowsky P; Bergman B; Hansen M; Hansen HH
J Clin Oncol; 1991 Sep; 9(9):1627-31. PubMed ID: 1651994
[TBL] [Abstract][Full Text] [Related]
39. Irinotecan plus cisplatin compared with etoposide plus cisplatin for small cell lung cancer: a randomized clinical trial.
Pan D; Hou M; Li H; Yu P; Liu J
Zhongguo Fei Ai Za Zhi; 2006 Oct; 9(5):443-6. PubMed ID: 21176468
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of celecoxib with cisplatin plus etoposide in extensive-stage small cell lung cancer.
Arúajo AM; Mendez JC; Coelho AL; Sousa B; Barata F; Figueiredo A; Amaro T; Azevedo I; Soares M
Cancer Invest; 2009 May; 27(4):391-6. PubMed ID: 19266367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]